Tissue Regenix Group plc (LON:TRX – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as GBX 35 ($0.45) and last traded at GBX 35.42 ($0.46), with a volume of 27614 shares. The stock had previously closed at GBX 36.50 ($0.47).
Tissue Regenix Group Trading Up 2.8 %
The company has a debt-to-equity ratio of 31.16, a current ratio of 4.03 and a quick ratio of 2.36. The business has a fifty day moving average of GBX 49.40 and a 200-day moving average of GBX 54.75. The stock has a market capitalization of £33.36 million, a price-to-earnings ratio of -38.20 and a beta of 1.61.
Tissue Regenix Group Company Profile
Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.
Further Reading
- Five stocks we like better than Tissue Regenix Group
- What is the MACD Indicator and How to Use it in Your Trading
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- Market Cap Calculator: How to Calculate Market Cap
- Top 3 Beverage Stocks Pouring Out Profits
- Growth Stocks: What They Are, Examples and How to Invest
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
